Cargando…

The SARS-CoV-2 Virus and the Cholinergic System: Spike Protein Interaction with Human Nicotinic Acetylcholine Receptors and the Nicotinic Agonist Varenicline

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is responsible for the worldwide coronavirus disease 2019 (COVID-19) pandemic. Although the pathophysiology of SARS-CoV-2 infection is still being elucidated, the nicotinic cholinergic system may play a role. To evaluate the interaction of...

Descripción completa

Detalles Bibliográficos
Autores principales: Carlson, Eric C., Macsai, Marian, Bertrand, Sonia, Bertrand, Daniel, Nau, Jeffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051900/
https://www.ncbi.nlm.nih.gov/pubmed/36982671
http://dx.doi.org/10.3390/ijms24065597
_version_ 1785015002203160576
author Carlson, Eric C.
Macsai, Marian
Bertrand, Sonia
Bertrand, Daniel
Nau, Jeffrey
author_facet Carlson, Eric C.
Macsai, Marian
Bertrand, Sonia
Bertrand, Daniel
Nau, Jeffrey
author_sort Carlson, Eric C.
collection PubMed
description Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is responsible for the worldwide coronavirus disease 2019 (COVID-19) pandemic. Although the pathophysiology of SARS-CoV-2 infection is still being elucidated, the nicotinic cholinergic system may play a role. To evaluate the interaction of the SARS-CoV-2 virus with human nicotinic acetylcholine receptors (nAChRs), we assessed the in vitro interaction of the spike protein of the SARS-CoV-2 virus with various subunits of nAChRs. Electrophysiology recordings were conducted at α4β2, α3β4, α3α5β4, α4α6β2, and α7 neuronal nAChRs expressed in Xenopus oocytes. In cells expressing the α4β2 or α4α6β2 nAChRs, exposure to the 1 µg/mL Spike-RBD protein caused a marked reduction of the current amplitude; effects at the α3α5β4 receptor were equivocal and effects at the α3β4 and α7 receptors were absent. Overall, the spike protein of the SARS-CoV-2 virus can interact with select nAChRs, namely the α4β2 and/or α4α6β2 subtypes, likely at an allosteric binding site. The nAChR agonist varenicline has the potential to interact with Spike-RBD and form a complex that may interfere with spike function, although this effect appears to have been lost with the omicron mutation. These results help understand nAChR’s involvement with acute and long-term sequelae associated with COVID-19, especially within the central nervous system.
format Online
Article
Text
id pubmed-10051900
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100519002023-03-30 The SARS-CoV-2 Virus and the Cholinergic System: Spike Protein Interaction with Human Nicotinic Acetylcholine Receptors and the Nicotinic Agonist Varenicline Carlson, Eric C. Macsai, Marian Bertrand, Sonia Bertrand, Daniel Nau, Jeffrey Int J Mol Sci Article Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is responsible for the worldwide coronavirus disease 2019 (COVID-19) pandemic. Although the pathophysiology of SARS-CoV-2 infection is still being elucidated, the nicotinic cholinergic system may play a role. To evaluate the interaction of the SARS-CoV-2 virus with human nicotinic acetylcholine receptors (nAChRs), we assessed the in vitro interaction of the spike protein of the SARS-CoV-2 virus with various subunits of nAChRs. Electrophysiology recordings were conducted at α4β2, α3β4, α3α5β4, α4α6β2, and α7 neuronal nAChRs expressed in Xenopus oocytes. In cells expressing the α4β2 or α4α6β2 nAChRs, exposure to the 1 µg/mL Spike-RBD protein caused a marked reduction of the current amplitude; effects at the α3α5β4 receptor were equivocal and effects at the α3β4 and α7 receptors were absent. Overall, the spike protein of the SARS-CoV-2 virus can interact with select nAChRs, namely the α4β2 and/or α4α6β2 subtypes, likely at an allosteric binding site. The nAChR agonist varenicline has the potential to interact with Spike-RBD and form a complex that may interfere with spike function, although this effect appears to have been lost with the omicron mutation. These results help understand nAChR’s involvement with acute and long-term sequelae associated with COVID-19, especially within the central nervous system. MDPI 2023-03-15 /pmc/articles/PMC10051900/ /pubmed/36982671 http://dx.doi.org/10.3390/ijms24065597 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Carlson, Eric C.
Macsai, Marian
Bertrand, Sonia
Bertrand, Daniel
Nau, Jeffrey
The SARS-CoV-2 Virus and the Cholinergic System: Spike Protein Interaction with Human Nicotinic Acetylcholine Receptors and the Nicotinic Agonist Varenicline
title The SARS-CoV-2 Virus and the Cholinergic System: Spike Protein Interaction with Human Nicotinic Acetylcholine Receptors and the Nicotinic Agonist Varenicline
title_full The SARS-CoV-2 Virus and the Cholinergic System: Spike Protein Interaction with Human Nicotinic Acetylcholine Receptors and the Nicotinic Agonist Varenicline
title_fullStr The SARS-CoV-2 Virus and the Cholinergic System: Spike Protein Interaction with Human Nicotinic Acetylcholine Receptors and the Nicotinic Agonist Varenicline
title_full_unstemmed The SARS-CoV-2 Virus and the Cholinergic System: Spike Protein Interaction with Human Nicotinic Acetylcholine Receptors and the Nicotinic Agonist Varenicline
title_short The SARS-CoV-2 Virus and the Cholinergic System: Spike Protein Interaction with Human Nicotinic Acetylcholine Receptors and the Nicotinic Agonist Varenicline
title_sort sars-cov-2 virus and the cholinergic system: spike protein interaction with human nicotinic acetylcholine receptors and the nicotinic agonist varenicline
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051900/
https://www.ncbi.nlm.nih.gov/pubmed/36982671
http://dx.doi.org/10.3390/ijms24065597
work_keys_str_mv AT carlsonericc thesarscov2virusandthecholinergicsystemspikeproteininteractionwithhumannicotinicacetylcholinereceptorsandthenicotinicagonistvarenicline
AT macsaimarian thesarscov2virusandthecholinergicsystemspikeproteininteractionwithhumannicotinicacetylcholinereceptorsandthenicotinicagonistvarenicline
AT bertrandsonia thesarscov2virusandthecholinergicsystemspikeproteininteractionwithhumannicotinicacetylcholinereceptorsandthenicotinicagonistvarenicline
AT bertranddaniel thesarscov2virusandthecholinergicsystemspikeproteininteractionwithhumannicotinicacetylcholinereceptorsandthenicotinicagonistvarenicline
AT naujeffrey thesarscov2virusandthecholinergicsystemspikeproteininteractionwithhumannicotinicacetylcholinereceptorsandthenicotinicagonistvarenicline
AT carlsonericc sarscov2virusandthecholinergicsystemspikeproteininteractionwithhumannicotinicacetylcholinereceptorsandthenicotinicagonistvarenicline
AT macsaimarian sarscov2virusandthecholinergicsystemspikeproteininteractionwithhumannicotinicacetylcholinereceptorsandthenicotinicagonistvarenicline
AT bertrandsonia sarscov2virusandthecholinergicsystemspikeproteininteractionwithhumannicotinicacetylcholinereceptorsandthenicotinicagonistvarenicline
AT bertranddaniel sarscov2virusandthecholinergicsystemspikeproteininteractionwithhumannicotinicacetylcholinereceptorsandthenicotinicagonistvarenicline
AT naujeffrey sarscov2virusandthecholinergicsystemspikeproteininteractionwithhumannicotinicacetylcholinereceptorsandthenicotinicagonistvarenicline